OBIECTIVE To observe the clinical efficacy and toxic effects of Mabthera(rituximab)in combination with the CHOP(R-CHOP)regimen for treating invasive B-cell non-
IntroductionUsually the alpha fetoprotein(AFP)concentration of patients with metastatic liver cancer iS slightly raised.Most of the levels are lower than 400 ug